Filgrastim biosimilar (Beijing SL Pharmaceutical)

非格司亭生物类似药（北京双鹭药业）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Beijing SL Pharmaceutical)

Drug Alias Name非格司亭生物仿制药（北京双鹭药业）Recombinant human granulocyte macrophage colony stimulating factor (Beijing SL Pharmaceutical)重组人粒细胞刺激因子（北京双鹭药业）rhG-CSF (Beijing SL Pharmaceutical)立生素 +[6]

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaNeutropenia

Original Approved Country/TerritoryMainland China

Original Approved Date1998/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesBeijing Sl Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Sl Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02